BACKGROUND: Epigallocatechin gallate (EGCG), the major component of tea polyphenol, has been reported to have various physiologic modulatory activities. Several reports also have shown that catechin has a protective effect against HIV infection, part of which is mediated by inhibiting virions to bind to the target cell surface. OBJECTIVE: We investigated the effect of EGCG on the expression of CD4 molecules and on its ability to bind gp120, an envelope protein of HIV-1. METHODS: Peripheral blood CD4+ T cells were incubated in the presence of EGCG, and the expression of CD4 was evaluated by means of flow cytometry. The effect of EGCG on the antibody binding to CD4 was investigated by using a sandwich ELISA, and the effect on the gp120 binding to CD4 was analyzed by means of flow cytometry. RESULTS: EGCG efficiently inhibited binding of anti-CD4 antibody to its corresponding antigen. This effect was mediated by the direct binding of EGCG to the CD4 molecule, with consequent inhibition of antibody binding, as well as gp120 binding. CONCLUSION: The present results suggest a potential preventive effect of EGCG on HIV-1 infection by modulating binding to CD4.
BACKGROUND:Epigallocatechin gallate (EGCG), the major component of tea polyphenol, has been reported to have various physiologic modulatory activities. Several reports also have shown that catechin has a protective effect against HIV infection, part of which is mediated by inhibiting virions to bind to the target cell surface. OBJECTIVE: We investigated the effect of EGCG on the expression of CD4 molecules and on its ability to bind gp120, an envelope protein of HIV-1. METHODS: Peripheral blood CD4+ T cells were incubated in the presence of EGCG, and the expression of CD4 was evaluated by means of flow cytometry. The effect of EGCG on the antibody binding to CD4 was investigated by using a sandwich ELISA, and the effect on the gp120 binding to CD4 was analyzed by means of flow cytometry. RESULTS:EGCG efficiently inhibited binding of anti-CD4 antibody to its corresponding antigen. This effect was mediated by the direct binding of EGCG to the CD4 molecule, with consequent inhibition of antibody binding, as well as gp120 binding. CONCLUSION: The present results suggest a potential preventive effect of EGCG on HIV-1 infection by modulating binding to CD4.
Authors: Pian Ye; Shuling Zhang; Lei Zhao; Jihua Dong; Shenghua Jie; Ran Pang; Shuli Li Journal: J Huazhong Univ Sci Technolog Med Sci Date: 2009-04-28
Authors: S M Lipson; G Karalis; L Karthikeyan; F S Ozen; R E Gordon; S Ponnala; J Bao; W Samarrai; E Wolfe Journal: Food Environ Virol Date: 2017-05-02 Impact factor: 2.778
Authors: J Shibata; S Ishihara; N Tada; K Kawai; N H Tsuno; H Yamaguchi; E Sunami; J Kitayama; T Watanabe Journal: Tech Coloproctol Date: 2015-03-12 Impact factor: 3.781
Authors: Ilona Hauber; Heinrich Hohenberg; Barbara Holstermann; Werner Hunstein; Joachim Hauber Journal: Proc Natl Acad Sci U S A Date: 2009-05-18 Impact factor: 11.205
Authors: Charles E Isaacs; Guang Y Wen; Weimin Xu; Jun Hua Jia; Lisa Rohan; Christopher Corbo; Vincenzo Di Maggio; Edmund C Jenkins; Sharon Hillier Journal: Antimicrob Agents Chemother Date: 2008-01-14 Impact factor: 5.191